Illustrative image – not actual.Ranbaxy Laboratories is reportedly planning to set up a
greenfield manufacturing unit in Vietnam. The company proposes to invest over
$10 million (approx. Rs.45 crore) in the unit over a five-year period.
The company is likely to sign a memorandum of understanding
with a local joint venture partner for setting up the facility.
Ranbaxy proposes to explore the huge untapped market in
Vietnam, especially in segments in which it specialises. The Vietnam facility will
focus on cardiovascular, anti-biotics and cough and cold segments.
